It is particularly interesting to study how patients with different tumor types can be affected during menopause: hormone receptor‐positive (HR+) tumors are driven by adipose‐derived molecules, making them more common in women with higher adiposity, and perhaps for this reason also in postmenopausal women (Bhardwaj & Brown, 2021; Dimauro et al., 2021). This evidence concerns the gene NR4A1 and neoplasm.